Cabotegravir PrEP Effective for U.S. Women Despite Injection Delays
No women taking long-acting cabotegravir (Apretude) for HIV pre-exposure prophylaxis (PrEP) developed an HIV infection, even when some experienced short delays before maintenance injections, according to … Read more